Molecular epidemiology of Streptococcus agalactiae recovered from significant bacteriuria

References

• Edwards MS, Baker CJ. Group B streptococcal infections in elderly adults. Clin Infect Dis 2005;41:839–47.
   PubMed Web of Science ®Google Scholar
• Falagas ME, Rosmarakis ES, Avramopoulos I, Vakalis N. Streptococcus agalactiae infections in non-pregnant adults: single center experience of a growing clinical problem. Med Sci Monit 2006;12:447–51.
   Google Scholar
• Ulett KB, Benjamin WHJR, Zhuo F, Xiao M, Kong F, Gilbert GL, et al. Diversity of group B streptococcus serotypes causing urinary tract infection in adults. J Clin Microbiol 2009;47:2055–60.
   PubMed Web of Science ®Google Scholar
• Magliano E, Grazioli V, Deflorio L, Leuci AI, Mattina R, Romano P, et al. Gender and age-dependent etiology of community-acquired urinary tract infections. Sci World J 2012;2012:349597.
   Google Scholar
• Matsumoto T, Hamasuna R, Ishikawa K, Takahashi S, Yasuda M, Hayami H, et al. Sensitivities of major causative organisms isolated from patients with acute uncomplicated cystitis against various antibacterial agents: results of subanalysis based on the presence of menopause. J Infect Chemother 2012;18:597–607.
   PubMedGoogle Scholar
• Trivalle C, Martin E, Martel P, Jacque B, Menard JF, Lemeland JF. Group B streptococcal bacteraemia in the elderly. J Med Microbiol 1998;47:649–52.
   PubMedGoogle Scholar
• Turan H, Serefhanoglu K, Torun AN, Kulaksizoglu S, Kulaksizoglu M, Pamuk B, et al. Frequency, risk factors, and responsible pathogenic microorganisms of asymptomatic bacteriuria in patients with type 2 diabetes mellitus. Jpn J Infect Dis 2008;61:236–8.
   PubMed Web of Science ®Google Scholar
• Edwards MS, Kasper DL, Jennings HJ, Baker CJ, Nicholson-Weller A. Capsular sialic acid prevents activation of the alternative complement pathway by type III, group B streptococci. J Immunol 1982;128:1278–83.
   PubMedGoogle Scholar
• Marques MB, Kasper DL, Pangburn MK, Wessels MR. Prevention of C3 deposition by capsular polysaccharide is a virulence mechanism of type III group B streptococci. Infect Immun 1992;60:3986–93.
   PubMed Web of Science ®Google Scholar
• Le Doare K, Heath PT. An overview of global GBS epidemiology. Vaccine 2013;31:7–12.
   PubMed Web of Science ®Google Scholar
• Palmeiro JK, Dalla-Costa LM, Fracalanzza SEL, Botelho ACN, Nogueira KS, Scheffer MC, et al. Phenotypic and genotypic characterization of group B streptococcal isolates in southern Brazil. J Clin Microbiol 2010;48:4397–403.
   PubMed Web of Science ®Google Scholar
• Souza VC, Kegele FOC, Souza SR, Neves FPG, Paula GR, Barros RR. Antimicrobial susceptibility and genetic diversity of Streptococcus agalactiae recovered from newborns and pregnant women in Brazil. Scand J Infect Dis 2013;45:780–5.
   PubMed Web of Science ®Google Scholar
• Usein CR, Militaru M, Cristea V, Straut M. Genetic diversity and antimicrobial resistance in Streptococcus agalactiae strains recovered from female carriers in the Bucharest area. Mem Inst Oswaldo Cruz 2014;109:189–96.
   PubMedGoogle Scholar
• Dahesh S, Hensler ME, Van Sorge NM, Gertz Jr RE, Schrag S, Nizet V, et al. Point mutation in the group B streptococcal pbp2x gene conferring decreased susceptibility to beta-lactam antibiotics. Antimicrob Agents Chemother 2008;52:2915–8.
   PubMed Web of Science ®Google Scholar
• Jannati E, Roshani M, Arzanlou M, Habibzadeh S, Rahimi G, Shapuri R. Capsular serotype and antibiotic resistance of group B streptococci isolated from pregnant women in Ardabil, Iran. Iran J Microbiol 2012;4:130–5.
   PubMedGoogle Scholar
• Faccone D, Guerriero L, Mendez E, Errecalde L, Cano H, Yoyas N, et al. Fluoroquinolone-resistant Streptococcus agalactiae isolates from Argentina. Rev Argent Microbiol 2010;42:203–7.
   PubMedGoogle Scholar
• Barros RR, Kegele FCO, Paula GR, Brito MA, Duarte RS. Molecular characterization of the first fluoroquinolone resistant strains of Streptococcus agalactiae isolated in Brazil. Braz J Infect Dis 2012;16:476–8.
   PubMedGoogle Scholar
• Wang H, Zhao C, He W, Zhang F, Zhang L, Cao B, et al. High prevalence of fluoroquinolone-resistant group B streptococci among clinical isolates in China and predominance of sequence type 19 with serotype III. Antimicrob Agents Chemother 2013;57:1538–41.
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention. Prevention of Perinatal Group B Streptococcal Disease Revised Guidelines from CDC, 2010. MMWR Morb Mortal Wkly Rep 2010;59:1–32
   PubMedGoogle Scholar
• Otaguiri ES, Morguette AE, Tavares ER, Santos PM, Morey AT, Cardoso JD, et al. Commensal Streptococcus agalactiae isolated from patients seen at University Hospital of Londrina, Parana, Brazil: capsular types, genotyping, antimicrobial susceptibility and virulence determinants. BMC Microbiol 2013;13:297.
   PubMed Web of Science ®Google Scholar
• CLSI. Performance standards for antimicrobial susceptibility testing, 23rd informational supplement, M100-S23. Clinical Laboratory Standards Institute; 2013 pp 112–16.
   Google Scholar
• Dmitriev A, Shakleina E, Tkacikova L, Mikula I, Totolian A. Genetic heterogeneity of the pathogenic potentials of human and bovine group B streptococci. Folia Microbiol (Praha) 2002;47:291–5.
   PubMed Web of Science ®Google Scholar
• Perez-Trallero E, Montes M, Orden B, Tamayo E, Garcia-Arenzana JM, Marimon JM. Phenotypic and genotypic characterization of Streptococcus pyogenes isolates displaying the MLSB phenotype of macrolide resistance in Spain, 1999 to 2005. Antimicrob Agents Chemother 2007; 51:1228–33.
   PubMed Web of Science ®Google Scholar
• Poyart C, Tazi A, Reglier-Poupet H, Billoet A, Tavares N, Raymond J, et al. Multiplex PCR assay for rapid and accurate capsular typing of group B streptococci. J Clin Microbiol 2007;45:1985–8.
   PubMed Web of Science ®Google Scholar
• Murayama SY, Seki C, Sakata H, Sunaoshi K, Nakayama E, Iwata S, et al. Capsular type and antibiotic resistance in Streptococcus agalactiae isolates from patients, ranging from newborns to the elderly, with invasive infections. Antimicrob Agents Chemother 2009;53:2650–3.
   PubMed Web of Science ®Google Scholar
• Beall B, Facklam R, Thompson T. Sequencing emm-specific PCR products for routine and accurate typing of group A streptococci. J Clin Microbiol 1996;34:953–8.
   PubMed Web of Science ®Google Scholar
• Teixeira LM, Carvalho MG, Merquior VL, Steigerwalt AG, Brenner DJ, Facklam RR. Phenotypic and genotypic characterization of Vagococcus fluvialis, including strains isolated from human sources. J Clin Microbiol 1997;35: 2778–81.
   PubMed Web of Science ®Google Scholar
• Correa AB, Silva LG, Pinto TCA, Oliveira IC, Fernandes FG, Costa NS, et al. The genetic diversity and phenotypic characterisation of Streptococcus agalactiae isolates from Rio de Janeiro, Brazil. Mem Inst Oswaldo Cruz 2011;106:1002–6.
   PubMed Web of Science ®Google Scholar
• Nakamura PA, Schuab RB, Neves FP, Pereira CF, Paula GR, Barros RR. Antimicrobial resistance profiles and genetic characterisation of macrolide resistant isolates of Streptococcus agalactiae. Mem Inst Oswaldo Cruz 2011;106:119–22.
   PubMedGoogle Scholar
• Kimura K, Wachino J, Kurokawa H, Suzuki S, Yamane K, Shibata N, et al. Practical disk diffusion test for detecting group B Streptococcus with reduced penicillin susceptibility. J Clin Microbiol 2009;47:4154–7.
   PubMedGoogle Scholar
• D’Oliveira RE, Barros RR, Mendonça CR, Teixeira LM, Castro AC. Susceptibility to antimicrobials and mechanisms of erythromycin resistance in clinical isolates of Streptococcus agalactiae from Rio de Janeiro, Brazil. J Med Microbiol 2003;52:1029–30.
   PubMedGoogle Scholar
• Duarte RS, Bellei BC, Miranda OP, Brito MA, Teixeira LM. Distribution of antimicrobial resistance and virulence-related genes among Brazilian group B streptococci recovered from bovine and human sources. Antimicrob Agents Chemother 2005;49:97–103.
   PubMed Web of Science ®Google Scholar
• Campelo FA, Pedrosa AC, Antunez IA, Capuz BL. Phenotypes and mechanisms of resistance to macrolides and lincosamides in Streptococcus agalactiae isolates with clinical significance in an eight-year period (2002–2010). Rev Esp Quimioter 2012;25:42–6.
   PubMedGoogle Scholar
• Lee WT, Lai MC. High prevalence of Streptococcus agalactiae from vaginas of women in Taiwan and its mechanisms of macrolide and quinolone resistance. J Microbiol Immunol Infect 2014 April 21 (Epub ahead of print).
   Google Scholar
• Belais S, Six A, Fouet A, Longo M, Dmytruk N, Glaser P, et al. Capsular switching in Group B Streptococcus CC17 hypervirulent clone: a future challenge for polysaccharide vaccine development. J Infect Dis 2012;206:1745–52.
   PubMedGoogle Scholar
• Florindo C, Damião V, Silvestre I, Farinha C, Rodrigues F, Nogueira F, et al. Epidemiological surveillance of colonising group B Streptococcus epidemiology in the Lisbon and Tagus Valley regions, Portugal (2005–2012): emergence of a new epidemic type IV/clonal complex 17 clone. Euro Surveill 2014;19. pii: 20825.
   PubMedGoogle Scholar
• Berti F, Campisi E, Toniolo C, Morelli L, Crotti S, Rosini R, et al. Structure of the type IX group B Streptococcus capsular polysaccharide and its evolutionary relationship with types V and VII. J Biol Chem 2014;289:23437–48.
   PubMed Web of Science ®Google Scholar